What is ChemPartner PharmaTech Co.,Ltd.'s (300149.SZ) StockRank?

MoatMap's StockRank for ChemPartner PharmaTech Co.,Ltd. (300149.SZ) is 15/100, with a Strong Sell signal. This is a composite score combining Quality (45), Value (26), and Momentum (32) factor ranks across MoatMap's 19,000+ stock universe.

Does ChemPartner PharmaTech Co.,Ltd. have an economic moat?

ChemPartner PharmaTech Co.,Ltd. (300149.SZ) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is ChemPartner PharmaTech Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for ChemPartner PharmaTech Co.,Ltd. (300149.SZ) is Strong Sell, based on a StockRank of 15/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is ChemPartner PharmaTech Co.,Ltd. in?

ChemPartner PharmaTech Co.,Ltd. (300149.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300149.SZ

STRONG SELLREMOVE

ChemPartner PharmaTech Co.,Ltd. · Healthcare · China · $642M · Avg Vol: $13M/d

StockRank

P/E (TTM)

—

ROE

-0.9%

D/E

0.3x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

While operating as a CRO/CDMO, ChemPartner is highly vulnerable to geopolitical tensions (e.g., US Biosecure Act) which are driving Western pharma clients away from Chinese service providers.

COMPANY DESCRIPTION

ChemPartner PharmaTech Co., Ltd. is a leading contract research organization (CRO) and contract development and manufacturing organization (CDMO) providing drug discovery and development services. The company offers integrated discovery chemistry, biology, pharmacology, and biologics development services to global pharmaceutical and biotech clients. Its competitive advantage is rooted in its highly experienced scientific team, state-of-the-art laboratory infrastructure, and a strong track record of international regulatory compliance.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	196M	168M	143M	168M	-5.1%
EPS	0.11	-0.27	-0.07	0.00	-65.5%
Shares	500M	500M	498M	498M	-0.4%
Debt	143M	94M	76M	69M	-21.4%
Equity	347M	212M	179M	189M	-18.4%
Op CF	39M	22M	25M	28M	-10.1%
Inv CF	149M	-2M	-10M	-10M	—
Fin CF	-127M	-57M	-13M	-12M	—

PRICE (1M)-21.8%

SMA 50SMA 200

$1.15

RSI (14)

28.1

52W High

$2.26

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

1.9%48.4

ROE

-0.9%43.8

GP/Assets

15.5%35.9

Op. Margin

-5.9%31.7

FCF/Assets

4.2%67.2

Piotroski

—55.8

Int. Cover

2.0x45.6

D/E Ratio

0.34x39.8

Current Ratio

2.13x39.4

Value

P/E (TTM)

—N/A

EV/EBITDA

96.8x3.2

P/FCF

345.2x24.7

P/B

3.0x39.2

P/S

3.4x53.2

Div Yield

—N/A

Momentum

52W High %

51%25.2

RS 6M

-29%42.7

SMA 50/200

0.91x37.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$642M

P/E (Forward)

19.5x

Gross Margin

27.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300149.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300149.SZ	ChemPartner PharmaTech Co.,Ltd.(you)	$642M	15	STRONG SELL
2105.HK	Laekna, Inc.	$666M	15	STRONG SELL
688302.SS	Hinova Pharmaceuticals Inc.	$582M	14	STRONG SELL
688136.SS	Kexing Biopharm Co., Ltd.	$626M	12	STRONG SELL
300318.SZ	Beijing Bohui Innovation Biotechnology Group Co., Ltd.	$613M	12	STRONG SELL
2591.HK	Guangzhou Innogen Pharmaceutical Group Co., Ltd	$648M	7	STRONG SELL
688639.SS	Anhui Huaheng Biotechnology Co., Ltd.	$868M	17	STRONG SELL
1167.HK	Jacobio Pharmaceuticals Group Co., Ltd.	$490M	12	STRONG SELL
2256.HK	Abbisko Cayman Limited	$826M	18	STRONG SELL
2157.HK	Lepu Biopharma Co., Ltd.	$981M	15	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

ChemPartner PharmaTech Co.,Ltd. (300149.SZ) — Stock Score Summary

ChemPartner PharmaTech Co.,Ltd. (300149.SZ) has a MoatMap StockRank of 15/100 based on Quality (45/100), Value (26/100), and Momentum (32/100) factor scores. The current signal is STRONG SELL. While operating as a CRO/CDMO, ChemPartner is highly vulnerable to geopolitical tensions (e.g., US Biosecure Act) which are driving Western pharma clients away from Chinese service providers.

Key Financial Metrics

Price	$1.15
Market Cap	$642M
P/E (Forward)	19.48
Price/Book	3.03
Return on Equity	-0.9%
Return on Invested Capital	1.9%
Debt/Equity	34.40
Gross Margin	27.5%
Operating Margin	-5.9%
Revenue Growth	2.1%
Free Cash Flow	$2M

ChemPartner PharmaTech Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is ChemPartner PharmaTech Co.,Ltd.’s (300149.SZ) StockRank?: MoatMap’s StockRank for ChemPartner PharmaTech Co.,Ltd. (300149.SZ) is 15/100, with a Strong Sell signal. It is a composite of Quality (45), Value (26), and Momentum (32) factor ranks across MoatMap’s 19,000+ stock universe.
Does ChemPartner PharmaTech Co.,Ltd. have an economic moat?: ChemPartner PharmaTech Co.,Ltd. (300149.SZ) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ChemPartner PharmaTech Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for ChemPartner PharmaTech Co.,Ltd. (300149.SZ) is Strong Sell, based on a StockRank of 15/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ChemPartner PharmaTech Co.,Ltd. in?: ChemPartner PharmaTech Co.,Ltd. (300149.SZ) operates in the Healthcare sector, specifically the Biotechnology industry (China).